| April 9, 2015 | ISSUE NUMBER 396 VOL 4 |
Pricing
Striking a Post-ACA Balance
Amidst the feverish debate over pricing in healthcare, the industry needs to focus on the value that healthcare can provide to patients and let that calculation dictate relative costs, writes David Ormesher ...Read more
Europe: Researching New Drugs “Needs Research into New Pricing Systems”
European national advisory bodies on pricing have written to the EU seeking funding for studies into how clinical and economic considerations can best interact. It's another demonstration of how far drug pricing concerns are invading the hitherto sacrosanct territory of drug development, writes Peter O‘ Donnell ...Read more
Celgene Saves $13 million Dollars with eCOA
Clinical trials are increasingly using site-based clinician assessments for endpoints. Learn how Celgene saved $13 million dollars using a site-based eCOA system for recently approved PsA therapy Otezla. Learn more
Is Your Sales Team Responsive to Market Changes?
“It is not the strongest of the species that survives... It is the one that is most responsive to change.” In today’s dynamic healthcare market, these words, long attributed to Charles Darwin, have never been more relevant, writes Brad Ansley ...Read more
Leadership
Deadline for Nomination: Pharm Exec's 2015 Emerging Pharma Leaders
Pharm Exec is looking for the fresh faces of pharma leadership, and we'd like your input! Tell us who you think should be included as one of Pharmaceutical Executive's 2015 Emerging Pharma Leaders. Read more for details of how to nominate a colleague — or yourself. The deadline for this year’s entries is April 15 ...Read more
Embedding patient centricity
Understanding the role of real-world evidence in global market access strategies
Live webinar: Tuesday, April 28, 2015 - 11.00 EDT, 17.00 CEST
Join Dr Louise Parmenter, and Dr Stella Blackburn from Qunitiles and Dr Seleen Ong from Pfizer as they discuss the importance of embedding patient centricity into the development of real-world evidence in global market access strategies.
Register for free: www.pharmexec.com/pe/quintiles-rwe
|
|
|
 //Otonomy (San Diego, CA) appointed Dean Hakanson, M.D., as Chief Medical Officer.//SteadyMed (San Ramon, CA) named David W. Nassif as its full time Executive Vice President and Chief Financial Officer.//Relmada Therapeutics (New York, NY) announced that it appointed Lisa Nolan, Ph.D., as Senior Vice President of Business Development.//Kathrin U. Jansen, Ph.D., was appointed Pfizer's Senior Vice President, Vaccine Research & Development.// |
|
|
|
|
|
